Clinical Trial Update: Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and efficacy data for LB80380 in lamivudine-refractory chronic hepatitis B in a combined Phase 1/2 study that has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• LB80380

Snippet

Sponsor: LG Life Sciences | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED